IFITM3 Antibodies

Santa Cruz Biotechnology offers a broad range of IFITM3 monoclonal antibodies for investigating Interferon-Inducible Transmembrane Protein 3 (IFITM3). IFITM3 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). IFITM3 plays a critical role in the immune response, particularly in the restriction of viral infections. IFITM3 inhibits the entry of a wide range of viruses, including influenza and HIV, thereby contributing to the host's defense mechanisms. Understanding IFITM3 function is essential for developing therapeutic strategies against viral diseases and enhancing vaccine efficacy. IFITM3 monoclonal antibodies enable researchers to explore cellular mechanisms of immune response and viral pathogenesis. IFITM3 research continues to reveal new insights about viral infection pathways and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies support scientific advancement by facilitating precise and reliable research in immunology and virology.